Literature DB >> 19073906

Chronic glucose infusion causes sustained increases in tubular sodium reabsorption and renal blood flow in dogs.

Michael W Brands1, Tracy D Bell, Nancy A Rodriquez, Praveen Polavarapu, Dmitriy Panteleyev.   

Abstract

This study tested the hypothesis that inducing hyperinsulinemia and hyperglycemia in dogs, by infusing glucose chronically intravenously, would increase tubular sodium reabsorption and cause hypertension. Glucose was infused for 6 days (14 mg.kg(-1).min(-1) iv) in five uninephrectomized (UNX) dogs. Mean arterial pressure (MAP) and renal blood flow (RBF) were measured 18 h/day using DSI pressure units and Transonic flow probes, respectively. Urinary sodium excretion (UNaV) decreased significantly on day 1 and remained decreased over the 6 days, coupled with a significant, sustained increase in RBF, averaging approximately 20% above control on day 6. Glomerular filtration rate and plasma renin activity (PRA) also increased. However, although MAP tended to increase, this was not statistically significant. Therefore, the glucose infusion was repeated in six dogs with 70% surgical reduction in kidney mass (RKM) and high salt intake. Blood glucose and plasma insulin increased similar to the UNX dogs, and there was significant sodium retention, but MAP still did not increase. Interestingly, the increases in PRA and RBF were prevented in the RKM dogs. The decrease in UNaV, increased RBF, and slightly elevated MAP show that glucose infusion in dogs caused a sustained increase in tubular sodium reabsorption by a mechanism independent of pressure natriuresis. The accompanying increase in PRA, together with the failure of either RBF or PRA to increase in the RKM dogs, suggests the site of tubular reabsorption was before the macula densa. However, the volume retention and peripheral edema suggest that systemic vasodilation offsets any potential renal actions to increase MAP in this experimental model in dogs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073906      PMCID: PMC2643985          DOI: 10.1152/ajpregu.90528.2008

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  42 in total

1.  Chronic thromboxane synthase inhibition prevents fructose-induced hypertension.

Authors:  D Galipeau; E Arikawa; I Sekirov; J H McNeill
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Inhibition of nitric oxide synthesis potentiates hypertension during chronic glucose infusion in rats.

Authors:  C R Claxton; M W Brands; S M Fitzgerald; J A Cameron
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

3.  Long-term glucose infusion increases arterial pressure in dogs with cyclooxygenase-2 inhibition.

Authors:  M W Brands; A E Hailman; S M Fitzgerald
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

4.  A single-injection method for measuring glomerular filtration rate.

Authors:  J E Hall; A C Guyton; B M Farr
Journal:  Am J Physiol       Date:  1977-01

Review 5.  The effect of insulin on renal sodium metabolism. A review with clinical implications.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

Review 6.  Insulin resistance and hypertension.

Authors:  James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-05       Impact factor: 4.733

7.  Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration.

Authors:  Rogerio B de Paula; Alexandre A da Silva; John E Hall
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

Review 8.  Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

Authors:  Shawna A Cooper; Adam Whaley-Connell; Javad Habibi; Yongzhong Wei; Guido Lastra; Camila Manrique; Sameer Stas; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-06-22       Impact factor: 4.733

9.  Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance.

Authors:  Kazuya Shinozaki; Kazuhide Ayajiki; Yoshihiko Nishio; Takeshi Sugaya; Atsunori Kashiwagi; Tomio Okamura
Journal:  Hypertension       Date:  2003-12-29       Impact factor: 10.190

10.  Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats.

Authors:  Yasuhiro Nishimoto; Takahito Tomida; Hideo Matsui; Takayuki Ito; Kenji Okumura
Journal:  Hypertension       Date:  2002-08       Impact factor: 10.190

View more
  5 in total

1.  Chronic sodium-retaining action of insulin in diabetic dogs.

Authors:  M Marlina Manhiani; Michael T Cormican; Michael W Brands
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

Review 2.  Sodium-retaining effect of insulin in diabetes.

Authors:  Michael W Brands; M Marlina Manhiani
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-10-03       Impact factor: 3.619

3.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

4.  Impaired fasting glucose is associated with renal hyperfiltration in the general population.

Authors:  Toralf Melsom; Ulla Dorte Mathisen; Ole C Ingebretsen; Trond G Jenssen; Inger Njølstad; Marit D Solbu; Ingrid Toft; Bjørn O Eriksen
Journal:  Diabetes Care       Date:  2011-05-18       Impact factor: 19.112

5.  Association of elevated glycosylated hemoglobin A1c with hyperfiltration in a middle-aged and elderly Chinese population with prediabetes or newly diagnosed diabetes: a cross-sectional study.

Authors:  Wen Hu; Hairong Hao; Weinan Yu; Xiaojuan Wu; Hongwen Zhou
Journal:  BMC Endocr Disord       Date:  2015-09-12       Impact factor: 2.763

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.